Cite
In-vivo activity and tolerance of conventional formulation versus fat emulsion formulation of amphotericin B in experimental disseminated candidiasis in neutropenic rabbits.
MLA
Chavanet, P., et al. “In-Vivo Activity and Tolerance of Conventional Formulation versus Fat Emulsion Formulation of Amphotericin B in Experimental Disseminated Candidiasis in Neutropenic Rabbits.” Journal of Antimicrobial Chemotherapy (JAC), vol. 39, no. 3, Mar. 1997, pp. 427–30. EBSCOhost, https://doi.org/10.1093/jac/39.3.427.
APA
Chavanet, P., Duong, M., Buisson, M., Hamel, H., Dubois, C., Bonnin, A., & Portier, H. (1997). In-vivo activity and tolerance of conventional formulation versus fat emulsion formulation of amphotericin B in experimental disseminated candidiasis in neutropenic rabbits. Journal of Antimicrobial Chemotherapy (JAC), 39(3), 427–430. https://doi.org/10.1093/jac/39.3.427
Chicago
Chavanet, P, M Duong, M Buisson, H Hamel, C Dubois, A Bonnin, and H Portier. 1997. “In-Vivo Activity and Tolerance of Conventional Formulation versus Fat Emulsion Formulation of Amphotericin B in Experimental Disseminated Candidiasis in Neutropenic Rabbits.” Journal of Antimicrobial Chemotherapy (JAC) 39 (3): 427–30. doi:10.1093/jac/39.3.427.